PA8636001A1 - Recubrimientos de azucar y metodos para la fabricacion de los mismos - Google Patents

Recubrimientos de azucar y metodos para la fabricacion de los mismos

Info

Publication number
PA8636001A1
PA8636001A1 PA20058636001A PA8636001A PA8636001A1 PA 8636001 A1 PA8636001 A1 PA 8636001A1 PA 20058636001 A PA20058636001 A PA 20058636001A PA 8636001 A PA8636001 A PA 8636001A PA 8636001 A1 PA8636001 A1 PA 8636001A1
Authority
PA
Panama
Prior art keywords
manufacture
methods
same
compositions
nucleos
Prior art date
Application number
PA20058636001A
Other languages
English (en)
Inventor
John C Clark
John C Michelucci
Deborah M Sherman
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PA8636001A1 publication Critical patent/PA8636001A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

COMPOSICIONES PARTICULARMENTE UTILES COMO RECUBRIMIENTOS PARA FORMULACIONES DE DOSIFICACION SOLIDA DE AGENTES TERAPEUTICOS SON PROPORCIONADAS, ASI COMO TAMBIEN SE PROPORCIONAN FORMULACIONES DE DOSIFICACION SOLIDA QUE COMPRENDEN TALES RECUBRIMIENTOS, PROCEDIMIENTOS PARA PREPARAR TALES FORMULACIONES DE DOSIFICACION SOLIDAS Y LOS PRODUCTOS DE ESOS PRECESOS. LAS COMPOSICIONES DE RECUBRIMIENTO, POR LO GENERAL, PROPORCIONAN UNA EXCELENTE RESISTENCIA AL TRIZAMIENTO, AUN CUANDO APLICADAS EN NUCLEOS DE TABLETAS FLEXIBLES / DILATADAS, TAL COMO NUCLEOS DEL TIPO DE HIDROGEL. LAS COMPOSICIONES TAMBIEN EXHIBEN EXCELENTES CARACTERISTICAS DE BLOQUE DE OLORES.
PA20058636001A 2004-06-07 2005-06-07 Recubrimientos de azucar y metodos para la fabricacion de los mismos PA8636001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57766804P 2004-06-07 2004-06-07

Publications (1)

Publication Number Publication Date
PA8636001A1 true PA8636001A1 (es) 2006-05-16

Family

ID=35351681

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20058636001A PA8636001A1 (es) 2004-06-07 2005-06-07 Recubrimientos de azucar y metodos para la fabricacion de los mismos

Country Status (23)

Country Link
US (2) US20050271724A1 (es)
EP (1) EP1753407B1 (es)
JP (1) JP5000509B2 (es)
CN (1) CN101267809A (es)
AR (1) AR049142A1 (es)
AU (1) AU2005251793B2 (es)
BR (1) BRPI0511663A (es)
CA (1) CA2566771A1 (es)
CR (1) CR8778A (es)
EC (1) ECSP067049A (es)
ES (1) ES2623363T3 (es)
GT (1) GT200500141A (es)
IL (1) IL179537A0 (es)
MX (1) MXPA06014229A (es)
NO (1) NO20070091L (es)
NZ (1) NZ551676A (es)
PA (1) PA8636001A1 (es)
PE (1) PE20060245A1 (es)
RU (1) RU2428178C2 (es)
SV (1) SV2006002136A (es)
TW (1) TW200602089A (es)
UA (1) UA86413C2 (es)
WO (1) WO2005120466A2 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0602397C1 (pt) * 2006-04-20 2009-11-24 Unicamp composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições
EP2042164A4 (en) * 2006-06-23 2010-10-13 Takeda Pharmaceutical STABILIZED SOLID PREPARATION
JP5198001B2 (ja) * 2006-06-23 2013-05-15 武田薬品工業株式会社 安定化された固形製剤
CN101495101B (zh) * 2006-07-25 2012-02-29 兴和株式会社 糖衣制剂及其制造方法
US20080175905A1 (en) * 2006-11-29 2008-07-24 Wyeth Estrogen/serm and estrogen/progestin bi-layer tablets
AU2008206476A1 (en) * 2007-01-12 2008-07-24 Wyeth Tablet-in-tablet compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
WO2009135067A1 (en) * 2008-05-01 2009-11-05 Wyeth Pharmaceutical polish formulations
WO2009158584A1 (en) * 2008-06-27 2009-12-30 Wyeth Dual adhesive technology
CN101744725B (zh) * 2008-12-09 2013-04-17 北京华素制药股份有限公司 缓释微丸包衣生产工艺参数的优化方法
US20120039954A1 (en) * 2008-12-15 2012-02-16 Somnus Therapeutics, Inc. Method of treating insomnia
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
US20110052687A1 (en) * 2009-08-26 2011-03-03 Glenmark Generics Ltd Extended release pharmaceutical composition of paliperidone
WO2011039768A2 (en) * 2009-09-17 2011-04-07 Cadila Healthcare Limited Pharmaceutical compositions for reducing alcohol-induced dose dumping
US8663671B2 (en) 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
WO2011112709A1 (en) * 2010-03-09 2011-09-15 Elan Pharma International Limited Alcohol resistant enteric pharmaceutical compositions
US9492395B2 (en) 2010-05-11 2016-11-15 Sensient Colors Llc Film coating composition and methods of making and using the same
EP2665477B1 (en) * 2011-01-20 2015-09-09 Bionevia Pharmaceuticals Inc. Modified release compositions of epalrestat or a derivative thereof and methods for using the same
US8846089B2 (en) * 2011-06-03 2014-09-30 Wakunaga Pharmaceutical Co., Ltd. Sugar-coated preparation and production method for the same
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
CN103977427A (zh) * 2014-05-08 2014-08-13 王�琦 一种糖衣产气粉配方及其制备方法
JP6504163B2 (ja) * 2014-06-02 2019-04-24 ニプロ株式会社 レーザー印刷用錠剤及びその製造方法
ES2951884T3 (es) * 2015-01-01 2023-10-25 Ideal Cures Pvt Ltd Novedosa composición de recubrimiento de película
EP3250225A1 (en) * 2015-01-29 2017-12-06 Novo Nordisk A/S Pharmaceutical composition for oral insulin administration comprising a tablet core and a polyvinyl alcohol coating
RU2588840C1 (ru) * 2015-03-26 2016-07-10 Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" Таблетки кветиапина с пролонгированным высвобождением и способ их получения
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
MX2019001238A (es) * 2016-08-04 2019-04-25 Bpsi Holdings Llc Recubrimientos faciles de tragar y sustratos recubiertos con estos.
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane
MX2019008440A (es) * 2019-07-15 2021-01-18 Dva Farma Mexicana S A De C V Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) * 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
JPS625910A (ja) * 1985-07-02 1987-01-12 Shin Etsu Chem Co Ltd 薄層糖衣錠の製造方法
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
CA2164344C (en) * 1993-08-30 2004-06-29 Stanley Lech Tablet coating based on a melt-spun mixture of a saccharide and a polymer
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
PL360916A1 (en) * 1999-03-29 2004-09-20 Wyeth Coating system
US6630166B1 (en) * 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
WO2003075918A1 (fr) * 2002-03-14 2003-09-18 Daiichi Suntory Pharma Co.,Ltd. Comprime contenant du chlorhydrate de pilsicainide (voie humide)

Also Published As

Publication number Publication date
BRPI0511663A (pt) 2008-01-02
AU2005251793A1 (en) 2005-12-22
CN101267809A (zh) 2008-09-17
TW200602089A (en) 2006-01-16
MXPA06014229A (es) 2007-05-04
RU2428178C2 (ru) 2011-09-10
AU2005251793B2 (en) 2010-07-15
IL179537A0 (en) 2007-05-15
AR049142A1 (es) 2006-06-28
PE20060245A1 (es) 2006-05-03
WO2005120466A3 (en) 2007-04-19
NZ551676A (en) 2010-11-26
RU2006140093A (ru) 2008-07-20
JP2008501803A (ja) 2008-01-24
UA86413C2 (ru) 2009-04-27
EP1753407B1 (en) 2017-03-08
JP5000509B2 (ja) 2012-08-15
WO2005120466A2 (en) 2005-12-22
ES2623363T3 (es) 2017-07-11
NO20070091L (no) 2007-01-05
EP1753407A2 (en) 2007-02-21
CA2566771A1 (en) 2005-12-22
ECSP067049A (es) 2007-02-28
CR8778A (es) 2007-10-01
US20050271724A1 (en) 2005-12-08
GT200500141A (es) 2006-01-10
US20110136772A1 (en) 2011-06-09
SV2006002136A (es) 2006-02-15

Similar Documents

Publication Publication Date Title
PA8636001A1 (es) Recubrimientos de azucar y metodos para la fabricacion de los mismos
GT200500325A (es) Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de quinasa
ECSP088298A (es) Modulacion de la expresion del receptor glucocorticoide
IL186104A (en) Phosphoramidate History of Nucleoside Compounds
ECSP11011067A (es) Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos
CL2007002513A1 (es) Compuestos derivados de isoindolina sustituidos, compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento y prevencion de enfermedades tales como cancer, dolor, degeneracion macular, entre otras.
NI201000050A (es) Derivados de pirrolo [2, 3-d] pirimidina como inhibidores de proteínas quinasas b.
CL2007002450A1 (es) Forma polimorfica i del enantiomero levogiro o dextrogiro de modafinilo; su procedimiento de preparacion; y composicion farmaceutica que los comprende (divisional solicitud 2693-03).
CR10304A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
CL2011000144A1 (es) Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros.
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
ECSP12011943A (es) Antagonistas de espiro-oxindol de mdm2
UY31068A1 (es) Ligandos purinoreceptores p2x, metodos para la prparacion de los mismos, composiciones farmaceuticas que los contienen y sus usos 570
UY30291A1 (es) Piridin(3,4-b)pirazinonas
CL2007002708A1 (es) Compuestos derivados de pirrolo[2,3-b]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, caquexia, trastornos inflamatorios, entre otros.
CL2009000135A1 (es) Compuestos derivados de 1,4-benzodiazepinas sustituidas, inhibidores de dipeptidilpeptidasa iv (dpp-iv); composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento de enfermedades tales como diabetes tipo 2, cataratas, glaucoma, hipertrofia prostatica benigna, cancer, entre otras; compuestos intermediarios.
PE20070723A1 (es) Imidazopirazinas como inhibidores de quinasas dependientes de ciclina
MX2007010359A (es) Trans carotenoides, su sintesis, formulacion y usos.
CL2013001459A1 (es) Compuestos derivados de quinazolincarboxamida azetidina; proceso para prepararlos; composicion farmaceutica que los comprende; set (kit); y su uso para el tratamiento de enfermedades hiperproliferativas tales como cancer, inflamacion, pancreatitis o enfermedad renal, dolor, hiperplasia benigna de piel entre otras.
AR060580A1 (es) Elastomeros de silicona que contienen antisepticos
UY28271A1 (es) Compuestos químicos
ECSP066322A (es) Derivados de 4-indolilsulfonamidas, su preparación y su uso como moduladores de 5-ht-6
WO2014110353A8 (en) Notch ligand bound biocompatible substrates and their use in bone formation
CL2012000097A1 (es) Compuestos derivados de 3-fenoximetilpirrolidina, inhibidores de la recaptacion de serotonina-norepinefrina; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica que lo comprende; y su uso en el tratamiento de trastornos del dolor, depresion, entre otros.
CR20110226A (es) Composición para tratar enfermedad